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Abstract
Purpose
The aim of this study was to evaluate the relevance of the three-dimensional (3D) structure
of breast microcalcifications (MC) as a predictor of malignancy using highly resolved micro-
computed tomography (micro-CT) datasets of biopsy samples.
Material and Methods
The study included 28 women with suspicious MC in their mammogram undergoing vac-
uum-assisted biopsy. Directly after the intervention, the specimens were scanned in a
micro-CT with an isometric spatial resolution of 9 μm. Datasets were analysed regarding the
number, volume and morphology of suspicious non-monomorphic MC (fl—fine linear, fp—
fine pleomorphic, ch—coarse heterogeneous) and the structure model index (SMI). Histo-
logical evaluation was performed according to the B-classification: normal tissue or benign
(group A: B1, B2), unclear malignant potential or suspicious of malignancy (group B: B3, B4)
and malignant lesions (group C: B5).
Results
In all groups, suspicious non-monomorphic MC were found: group A exhibited fp MC in
38.5% of samples, no fl/ch; group B: fl 14.3%, fp 28.6%, ch 14.3%; group C always had at
least one type of suspicious non-monomorphic MC (fl (57.1%) or fp (57.1%)) in each sam-
ple. The different histologic groups showed a similar mean SMI (benign: 2.97 ± 0.31, malig-
nant: 3.02 ± 0.10, unclear: 2.90 ± 0.28). Between the three groups, no significant differences
were found regarding number, volume or SMI value of MC.
Conclusion
3D structure based on the SMI of MC analysed with highest spatial resolution is not signifi-
cantly associated with the B-classification of breast lesions. Thus, magnification views of
MC may be omitted in the analysis of MC detected in mammograms.
PLOS ONE | DOI:10.1371/journal.pone.0169349 January 20, 2017 1 / 12
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Kenkel D, Varga Z, Heuer H, Dedes KJ,
Berger N, Filli L, et al. (2017) A Micro CT Study in
Patients with Breast Microcalcifications Using a
Mathematical Algorithm to Assess 3D Structure.
PLoS ONE 12(1): e0169349. doi:10.1371/journal.
pone.0169349
Editor: Yudong Zhang, Nanjing Normal University,
CHINA
Received: May 23, 2016
Accepted: December 15, 2016
Published: January 20, 2017
Copyright: © 2017 Kenkel et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: The authors received no specific funding
for this work.
Competing Interests: The authors have declared
that no competing interests exist.
Introduction
Breast cancer is the most frequent malignancy in women, with yearly 1.38 million new breast
cancer cases worldwide representing 10.9% of all new diagnosed cancer [1]. The World Health
Organization (WHO) predicts that the importance of breast cancer is likely to increase in the
next decades in developing and developed countries due to the increased incidence of breast
cancer caused by increased life expectancy [2]. These circumstances urge an improvement in
early diagnosis, firstly to improve the outcome of patients and secondly to reduce the health-
care costs related to breast cancer therapy. In Canada, for instance, the average lifetime cost
per breast cancer case was higher at higher stages ($36,340 for stage IV) compared to lower
stages ($23,275 for stage I) [3].
Mammography screening is the current gold standard for the early detection of breast can-
cer. The evaluation of mammograms is standardized according to the American College of
Radiology (ACR) Breast Imaging Reporting and Data System (BIRADS) classification. One of
the key findings for the detection of suspicious breast lesions and an important sign of malig-
nancy is microcalcifications (MC) [4, 5]. Typically, the shape of the MC in breast lesions is
used to classify the finding as benign or malignant [6–9]. According to the BIRADS classifica-
tion, there are three categories of MC including typically benign, MC of intermediate concern
and calcification with a high probability of malignancy. Benign calcifications are mostly larger,
calcifications of intermediate concern are coarse heterogeneous and typical malignant MC are
fine pleomorphic and fine linear [10].
Mammography is the only screening method that has been proved to be efficient and cost-
effective [11–13]. The early diagnosis of breast cancer causes a decrease in the mortality associ-
ated with the disease [14]. A meta-analysis including 11 randomized trials showed that the rel-
ative risk reduction of women taking part in the screening compared to a control group not
undergoing mammography screening is 20% (95% CI 0.73–0.89) [15].
The aim of this study is to evaluate whether mathematical modelling of the three-dimen-
sional (3D) structure of MC may serve as an objective predictor of malignancy as proved by
minimal invasive breast biopsy histological diagnostics.
Methods
Subjects
Patients with MC classified as BIRADS 2–5 without corresponding findings in the ultrasound
examinations were prospectively included in this study. Twenty-nine biopsy specimens of 28
women (age range 50–86 years, mean age 60.5 ± 8.8 years) were evaluated. Informed consent
was obtained from each patient; all patients signed a written informed consent that their tissue
can be used for further imaging and histological research. The Department of Pathology and
Molecular Pathology, University Hospital Zurich included this study into a larger breast
pathology project (KEK-2012-554). There was no need for a specific approval of this subproj-
ect by the local ethical committee, as informed consent was available in each patient and only
the histological diagnosis of the minimal invasive breast biopsies were included in the study
without any further analyses on the breast tissues.
Mammography
The patients were examined using a mammography system (MAMMOMAT Inspiration; Sie-
mens AG, Healthcare Sector, Erlangen, Germany) in the two standard projections: mediolat-
eral oblique view and craniocaudal view. All mammographies were classified according to the
BIRADS classification [7]. Prior to biopsy, mammographies were discussed by an
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interdisciplinary board including radiologists and gynaecologists; after biopsy, histological
results were discussed by an interdisciplinary board between pathologists, radiologists and
gynaecologists.
Breast biopsy
Patients underwent vacuum-assisted stereotactic breast biopsy using an EnCor Enspire breast
biopsy system (Bard, Tempe) with a needle size of 7 gauge or 10 gauge. Patients were rested in
a prone position on the biopsy table. The biopsies were executed by a senior attending physi-
cian from the Department of Gynaecology or the Department of Radiology. Immediately after
extraction, samples were fixed in formalin.
Micro-CT imaging
Each specimen was removed from the formalin-filled tube and covered with plastic wrap in
order to protect the sample from drying during measurement. Imaging was performed on a
micro-CT system (SkyScan 1176, Bruker microCT, Kontich, Belgium). The biopsies were posi-
tioned in the isocentre of the micro-CT bed and stabilized with adhesive tape. Images were
acquired after a localizer scan using the following scan parameters: rotation step 0.5˚, tube
voltage 90 kV, tube current 280 μA, covered angle 360˚, copper filter 0.1 mm, voxel size 9 × 9 ×
9 μm3. The total scanning time for each sample was 120 min. Images were then reconstructed
using a modified Feldkamp cone-beam algorithm (NRecon, SkyScan/Bruker microCT, Kon-
tich, Belgium). The applied MicroCT Skyscan 1176 uses a Feldkamp filtered backprojection
reconstruction for cone-beam CTs. In principle, the reconstruction of each single image is per-
formed in two dimensions, however, as a volume dataset is acquired the 2D slice are recon-
structed with isotropic voxel size.
Image analysis
After reconstruction, different morphological parameters were calculated using CTAn/CTVol
(SkyScan/Bruker microCT) including the object volume and SMI. For assessment of the 3D
structure of the MC the structure model index (SMI) was calculated. SMI is a dimensionless
quantity, that is defined according to the following equation of Hildebrand et al [16]:
SMI ¼ 6 
S0  V
S2
 
where S is the object surface area before dilation, S’ is the change in surface area caused by dila-
tion and V is the undilated object volume. SMI ranges from 0 to 4: a value of 0 signifying a
plate-like structure, 3 a cylindrical structure and 4 a sphere. Intermediate values indicate a
mixed structure. Further, for each sample the mean object volume and the diameter assuming
spherical and cubic shape were calculated.
In analogy to the BIRADS classification, the MC were categorized according to the follow-
ing scheme: fine linear (fl) MC defined as calcifications with a mean estimated diameter (cube)
of< 200 μm and an SMI of 2.92–3.08, fine pleomorphic (fp) with a mean estimated diameter
(cube) of< 250 μm and a standard deviation (SD) of the SMI of more than 0.29, coarse hetero-
geneous (ch) defined as calcifications with an estimated diameter > 500 μm and an SD of the
SMI > 0.5 and no suspicious MC defined if none of the other definitions is accurate.
Histological evaluation
The specimens were fixed in 4% formaldehyde and processed and stained according to the
standard procedures including serial sections and hematoxylin and eosin staining. Histological
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diagnoses were made based on the current B-classification [17]. The B1 category indicates nor-
mal tissue that might show MC, e.g. within involutional lobules. The B2 category includes
benign lesions such as fibroadenomas, fibrocystic changes, ductectasia and sclerosing adenosis.
B3 lesions are of uncertain malignant potential including atypical ductal hyperplasia (ADH),
classical lobular neoplasia (LN), phylloides tumours and papillary lesions. The B4 category
contains suspicious lesions for malignancy, but not affirmative diagnostic for malignancy.
Lesions categorized as B5 lesions are definitely malignant [18, 19].
Statistical analysis
The mean and SD of the size and the morphological parameters were calculated. Data were
tested for normal distribution using the Kolmogorov–Smirnov (KS-test). The means of the
morphological parameters of the different histological groups were compared using an inde-
pendent samples Kruskal–Wallis test and the chi-square test was used to compare the amount
of BIRADS-MC with the histological groups, including those which were histologically proven
to be normal or benign (group A: B1 and B2), of uncertain potential or suspicious (group B:
B3 and B4) and malignant (group C: B5). Due to the multiple comparisons, a Bonferroni cor-
rection was performed. The data were analysed using IBM SPSS-Statistics version 22. A p-
value of less than 0.05 was considered to be significant.
Results
Subjects and histology
In 29 biopsies from 28 patients 829 MC were detected resulting in a mean number of MC of
28.6 ± 34.7 per specimen. The majority of the examined patients were radiologically consid-
ered to be BIRADS 4 (n = 25), two were assessed as BIRADS 5, one lesion was classified as BIR-
ADS 2 and one lesion as BIRADS 3. The histology showed that 8 of 27 biopsies were malignant
(29.6%). Table 1 gives an overview of the patients age, the histological (B-classification) and
radiological (BIRADS) evaluation. For the morphologic evaluation, two samples containing
just one MC were excluded. At the interdisciplinary board these biopsies were considered to
be non-representative since more than one MC was observed on the mammograms.
Morphological evaluation using micro-CT
Table 2 reports the results of the morphological parameters (number of MC, mean object vol-
ume, morphology, mean SMI) for each sample. No significant differences between benign
(group A) lesions, lesions with unclear malignant potential (group B) and malignant (group C)
lesions were observed regarding the number of MC (P = 0.113), object volume (P = 0.881),
mean SMI (P = 0.756) or the SD of the SMI (P = 0.976). Table 3 and Fig 1 show the results of
the different morphological parameters including number of MC, object volume and mean
SMI for group A–C lesions. The different histologic groups exhibited a similar mean SMI
(group A: 2.97 ± 0.31, group B: 2.90 ± 0.28, group C: 3.02 ± 0.1) and SD of the SMI (group A:
0.32 ± 0.19, group B: 0.32 ± 0.18, group C: 0.31 ± 0.11. Moreover, group C lesions (33.6 ± 12.8)
showed a tendency to comprise fewer calcifications than group B lesions (41.4 ± 52.7) and
more than group A lesions (23.2 ± 32.6), without reaching significance.
Categorization of MC
Table 2 reports the presence of different types of MC for each specimen and Table 3 provides
an overview for group A–C lesions. Group A lesions showed no fine linear or coarse heteroge-
neous MC; fine pleomorphic were found in 38.5% (5/13) of the samples and no suspicious MC
Breast Microcalcifications Using a Mathematical Algorithm to Assess 3D Structure: A Micro CT Study
PLOS ONE | DOI:10.1371/journal.pone.0169349 January 20, 2017 4 / 12
were found in 61.5% (8/13). Group B lesions exhibited a more heterogeneous distribution of
MC types than group A and C lesions: fine linear in 14.3% of samples (1/7), fine pleomorphic
in 28.6% (2/7), coarse heterogeneous in 14.3% (1/7) and no suspicious calcification in 42.9%
(3/7) of the samples. Group C lesions always showed at least one type of suspicious MC: 57.1%
of the samples exhibited fine linear (4/7) and 57.1% showed fine pleomorphic MC (4/7).
A chi-square test demonstrated that the absence of suspicious MC between groups A–C
was not significant after Bonferroni correction (P = 0.028); however, the presence of fine linear
MC was significantly different between groups A–C (P = 0.007). No significant differences
were observed regarding the presence of fine pleomorphic (P = 0.539) and coarse heteroge-
neous MC (P = 0.227) between the groups.
Table 1. Patient age and overview of the histologic (B-classification) and radiologic (BIRADS) evaluation.
Sample
number
B-
classification
BIRADS A, normal or benign B, unclear biological
potential or suspicious C, malignant
Patient age
(years)
Histological diagnosis
1 B2 4 A 52 Fibrosis, apocrine metaplasia
2 B1 4 A 58 Fibrosis, no calcifications
3 B2 4 A 58 Fibrosis with calcifications
4 B2 4 A 63 Fibrosis, sclerosing adenosis
5 B2 4 A 57 Fibrosis, sclerosing adenosis
6 B2 4 A 65 Fibrosis, sclerosing adenosis, usual ductal
hyperplasia, intraductal papilloma.
7 B2 4 A 57 Fibroadenoma
8 B2 4 A 52 Fibrosis, sclerosing adenosis
9 B1 2 A 60 Lipomatosis and ectasia of the ducts
10 B2 4 A 53 Usual ductal hyperplasia
11 B2 4 A 74 Sclerosing adenosis, usual ductal hyperplasia,
12 B2 4 A 59 Fibrosis, usual ductal hyperplasia
13 B2 4 A 54 Fibrotic duct
14 B2 4 A 54 Lipomatosis
15 B4 4 B 60 ADH
16 B3 4 B 65 Intraductal papilloma, apocrine metaplasia,
usual ductal hyperplasia
17 B3 4 B 54 ADH in an inflammatory lobulus
18 B3 4 B 52 Flat epithelial atypia
19 B3 4 B 52 Sclerosing adenosis, fibrosis,
microcalcifications at the end of the ducts
20 B3 4 B 86 Classical Lobular neoplasia, sclerosing
adenosis, scar
21 B3 4 B 52 Classical Lobular neoplasia
22 B5 5 C 76 DCIS high grade
23 B5 4 C 52 DCIS non-high grade
24 B5 5 C 49 DCIS high-grade and lymphangiosis
carcinomatosa
25 B5 4 C 60 DCIS high grade
26 B5 4 C 69 Invasive carcinoma (ductal type,NST)
27 B5 4 C 63 DCIS high-grade in transition to invasive
carcinoma (ductal type, NST)
28 B5 4 C 70 DCIS mainly non high grade focally high grade
29 B5 3 C 74 DCIS non high grade
doi:10.1371/journal.pone.0169349.t001
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Table 2. Morphological parameters including object volume (μm3x105) and the structure model index (±SD) of every specimen. Morphology: fl: fine
linear, fp: fine pleomorphic, ch: coarse heterogeneous, ns: no suspicious MC, 1 indicating presence and 0 indicating absence of the respective type of
microcalcification.
Sample Number Group Number of MC Mean object volume [μm3x105] Morphology SMI mean (±SD)
fl fp ch ns
1 A 23 16 0 1 0 0 3.27±0.33
2 A 1 1 1 0 0 0 3.02±0
3 A 13 65 0 1 0 0 2.95±0.39
4 A 5 6 0 1 0 0 2.79±0.45
5 A 11 30 0 0 0 1 3.14±0.18
6 A 53 28 0 0 0 1 3.30±0.28
7 A 18 325 0 0 0 1 2.76±0.35
8 A 121 43 0 0 0 1 3.29±0.29
9 A 10 82 0 0 0 1 3.07±0.12
10 A 5 25 0 1 0 0 2.19±0.80
11 A 31 13 0 0 0 1 3.30±0.18
12 A 2 2 0 0 0 1 2.86±0.04
13 A 6 737 0 0 0 1 2.89±0.24
14 A 4 7 0 1 0 0 2.89±0.45
15 B 5 473 0 0 1 0 2.59±0.60
16 B 36 40 0 1 0 0 2.52±0.45
17 B 7 9 0 0 0 1 3.14±0.09
18 B 150 22 0 0 0 1 3.15±0.24
19 B 15 37 0 1 0 0 2.75±0.46
20 B 67 22 1 0 0 0 3.07±0.24
21 B 10 16 0 0 0 1 3.10±0.20
22 C 58 36 1 0 0 0 2.95±0.25
23 C 25 14 1 0 0 0 3.00±0.27
24 C 30 15 0 1 0 0 2.87±0.54
25 C 31 19 1 0 0 0 3.03±0.20
26 C 1 3 0 0 0 1 2.79±0
27 C 30 87 0 1 0 0 3.11±0.31
28 C 19 152 0 1 0 0 3.15±0.30
29 C 42 70 1 1 0 0 3.08±0.30
doi:10.1371/journal.pone.0169349.t002
Table 3. Overview of the results of different morphological parameters including mean SMI, SD SMI, mean number of calcifications, the object vol-
ume for histologically proven benign, malignant and unclear biological potential lesions. Moreover the presence of the morphological MC types in the
different groups is reported.
Group A: benign Group B: unclear malignant potential Group C: malignant
Morphological parameters
Mean SMI 2.97±0.31 2.90±0.28 3.03±0.1
SD SMI 0.32±0.19 0.32±0.18 0.31±0.11
Object volume (μm3x105) 106±207 88±169 56±50
Mean number of microcalcifications 23.2±32.6 41.4±52.7 33.6±12.8
Morphology of MC
Fine linear 0/13 1/7 4/7
Fine pleomorphic 5/13 2/7 4/7
Coarse heterogeneous 0/13 1/7 0/7
No suspicious calcification 8/13 3/7 0/7
doi:10.1371/journal.pone.0169349.t003
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Fig 2 shows representative 3D images from different biopsies from group A (A–C), group B
(D–F) and group C lesions (G–I). Typically, group C lesions (H and I) exhibited fine linear
MC more often than group A lesions, which never showed a fine linear pattern (A–C). Group
B lesions showed the broadest variety of MC including all kinds of MC and also lesions with
no suspicious MC. In Fig 3, it is demonstrated that the different types of MC can easily be
assessed in micro-CT images due to the excellent spatial resolution.
Discussion
In the present study, we examined the form and morphological characteristics of MC detected
by mammography. Samples from vacuum-assisted stereotactic breast biopsy underwent
micro-CT measurements with a highest spatial resolution of 9 μm; the MC were 3D-seg-
mented with subsequent morphological analysis using an automatic algorithm providing the
number of MC, volume and SMI. Moreover, MC were categorized as suspicious MC exhibit-
ing a fine linear, fine pleomorphic or coarse heterogeneous pattern. None of the morphological
parameters or any of the types of suspicious MC showed a statistical correlation to the B-classi-
fication type of the lesion. Therefore, the 3D shape of the MC does not allow benign lesions to
be distinguished from lesions with unknown malignant potential or breast cancers.
In our study, 93% of the examined patients showed lesions radiologically classified as BIR-
ADS 4 and 5; in the histological examination of the biopsy samples 29.6% were classified as B5
lesions corresponding to a positive predictive value (PPV) of suspicious MC in mammograms
of approximately 30% at our institution. This estimated PPV is in accordance with other stud-
ies reporting a PPV in the order of 30–50% for MC undergoing biopsy [4, 5]; therefore, it may
be assumed that a typical mammography screening cohort was evaluated in this prospective
analysis.
Only one other study assessing the 3D shape of MC using micro-CT has been previously
published, by Willekens et al [20]. Compared to the Willekens study, we applied a substantially
higher isotropic spatial resolution of 9 μm compared to 35 μm. Further, Willekens et al
excluded MC that were smaller than three micro-CT voxels, only analysing calcifications larger
than 105 μm. Furthermore, a nearly three times larger sample size was included in our study,
compared to the 11 samples evaluated in the Willekens study. Some of our findings are in line
with the data of Willekens et al: Patients with histologically proven benign lesions had fewer
MC than those with malignant lesions; this finding was, however, not significant in our study.
Fig 1. Overview of different morphological parameters including mean number, volume (μm3) and SMI of MC for all different
groups (benign: including B-classification B1 and B2; unclear malignant potential: including B-classification B3 and B4;
malignant lesions: including B-classification B5). Error bars indicate the standard error of the mean (SEM).
doi:10.1371/journal.pone.0169349.g001
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Likewise, our study demonstrated that SMI values do not allow distinction between malignant
and benign lesions.
The category of B3 lesions comprises a heterogeneous group of different histological lesion
types including atypical hyperplasia (AH) with ADH and classical LN including atypical lobu-
lar hyperplasia (ALH) and classical lobular carcinoma in situ, flat epithelial atypia (FEA), phyl-
loides tumour, papillary lesions and radial scars. Often, B3 lesions undergoing resection are
later upgraded to B5 lesions because of a small invasive focus in the removed tissue [19, 21].
The B3 and B4 lesions included in our study showed a wide variety of different types of MC
with one type of suspicious MC. However, two preliminary aspects were discovered for which
a high resolved depiction of MC might provide additional helpful information. Statistically sig-
nificant differences between groups A and C were detected regarding the presence of fine lin-
ear MC. Fine linear MC were only present in groups B and C; therefore, the subtype of fine
linear MC seems to be a potential predictor of malignancy or lesions of unknown malignant
potential. Moreover, each malignant lesion showed at least one type of suspicious MC, whereas
benign lesions in the majority of cases did not show suspicious MC, demonstrating that the
absence of suspicious MC might be a weak predictor for the benignancy of a lesion. In our
Fig 2. Representative 3D images from different biopsies. Benign (group A: A–C) lesions, unclear biological potential lesions (group B:
D–F) and malignant (group C: G–I) lesions: A (sample number 1, fine pleomorphic), B (sample number 6, no suspicious MC), C (sample
number 7, no suspicious MC), D (sample number 15, coarse heterogeneous), E (sample number 16, fine pleomorphic), F (sample number
20, fine linear), G (sample number 22, fine linear), H (sample number 25, fine linear) and I (sample number 24, fine pleomorphic). For more
details concerning the different samples, compare sample numbers in Tables 1 and 2.
doi:10.1371/journal.pone.0169349.g002
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Fig 3. Representative 3D images and mammograms from two different patients. Left column: sample number 6 (fibrosis, sclerosing
adenosis, normal ductal hyperplasia, intraductal papilloma), only spherical MC classified as no suspicious MC; right column: sample number
25 (DCIS high grade), fine linear MC. CC indicates craniocranialcaudal view and MLO indicates mediolateral oblique view.
doi:10.1371/journal.pone.0169349.g003
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study these differences were not significant; this could be attributed to a sample size that was
too low to detect such rather weak correlations.
Several approaches have been undertaken to improve the assessment of MC including X-
ray magnification views [4, 6, 22–29] and computer-aided detection with partially successful
results: the contrast-limited adaptive histogram equalization (CLAHE) technique for example
showed promising results for the computer-aided detection in digital mammograms with a
sensitivity of 92.54% and a specificity of 92.50% [30]. However, assessment of the real 3D
structure of MC remains challenging in 2D projection views. A technique offering the possibil-
ity of obtaining a 3D view is breast tomosynthesis [31]. If tomosynthesis could reach a resolu-
tion high enough to distinguish fine linear MC from fine pleomorphic MC, an increase of the
PPV of X-ray breast imaging with a reduction of over-diagnosis and avoidance of unnecessary
biopsies might become feasible. Although tomosynthesis might be a promising tool in the
future it has to be taken into account that, in general, CT images suffer from noise and arti-
facts, especially in low dose mode. Therefore, previously published special low dose imaging
algorithms should be implemented [32–36].
Our study also has limitations: (a) a relatively small sample size was evaluated with hetero-
geneous findings regarding histology. A larger cohort might provide a deeper insight into
whether the fine linear MC subtype exhibits a predictive value for the presence of malignancy.
It would be desirable to have a database like the Mammographic Image Analysis Society
(MIAS) database of digital mammograms. This database contains 322 digitizeddigitised films.
To the best of our knowledge there is no public micro-CT database of breast MC. However, we
believe that a database would be desirable for the assessment of MC since it would allow the
evaluation of a higher sample size. (b) Further, we only assessed the micro-CT images alone.
Consecutively, other predictors of malignancy like the distribution of calcification, which is
just visible on the mammograms, were not taken into account. (c) We only assessed the Struc-
tural Model Index SMI. However, it has to be mentioned that there are many other descriptors
for the 3D structure, e.g. fractal dimension [37]. However, the evaluation of other assessment
measures was beyond the scope of this study.
In conclusion, we showed that the shape (based on the SMI) of MC assessed even with high-
est spatial resolution using micro-CT is not significantly associated with the B-classification of
the underlying lesion, especially regarding the presence of malignancy. Taken together, it
seems to be justified to omit magnification views for the assessment of MC.
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